"Weight loss brings impressive improvement in the control of diabetes," says Dr. Gary Foster, Director of the Center for Obesity Research and Education at Temple University School of Medicine, Chair of Nutrisystem's Scientific Advisory Board and head of the research team for Nutrisystem's first clinical trial. "A structured plan empowers overweight people with type 2 diabetes to transition from feeling overwhelmed by meal planning to instead making appropriate food choices that can have a positive impact on weight loss and blood glucose."A third study, which used continuous glucose monitoring, compared glycemic control and variability during consumption of Nutrisystem D and participants' usual diets. While consuming Nutrisystem D, participants had lower average blood glucose and less variability. Glycemic variability – or fluctuations in blood sugar levels – is an independent risk factor that can contribute to complications of diabetes.
Nutrisystem Debuts Its Enhanced Nutrisystem D Diet Plan Specifically Designed For People With Type 2 Diabetes
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.